Nexus Ventures — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Iambic Therapeutics, Inc.Apr 2026SEC filingmedium confidence
BiotechSan Diego, US
Fred Manby(Executive Officer, Director)Thomas Miller(Executive Officer, Director)Neil Josephson(Executive Officer)Michael Secora(Executive Officer)Pete Olson(Executive Officer)Chao Zhang(Executive Officer)
Board seatJishnu Bhattacharjee· per SEC Form D · $50M raise · filed Apr 2026
Co-investorsAbingworthNexus Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.